BEIJING (Reuters): Sinovac Biotech said on Saturday that its unit’s COVID-19 vaccine has been approved for use by the general public by China’s medical products regulator.

It marks the second COVID-19 vaccine approved for public use in China, after a shot developed by a Beijing institute affiliated to state-owned China National Pharmaceutical Group (Sinopharm) was approved in December.…

The post China approves Sinovac COVID-19 vaccine for general public use appeared first on ChinaPulse.com.